160
M. Zhang et al. / Carbohydrate Research 318 (1999) 157–161
3-C-(1,2-O-Isopropylidene-h-
D
-xylofuranos-
(8).—Com-
(s, 2 H, –NH2, exchangeable); FABMS: m/z
457 [M+1]+.
3-yl)-5-phenyl-1,2,4-oxadiazole
pounds 5, 6 or 7 were treated with NaOMe in
MeOH at pH 7–8 for 1 h at rt, to give the
same product 8 in yields of 72–95%, mp
156–157 °C, [h]1D8 +126.2° (c 0.96, EtOAc);
1H NMR (Me2SO-d6): 1.20 (s, 3 H, CH3), 1.33
(s, 3 H, CH3), 3.64 (m, 1 H, H-5b%), 3.77 (m, 1
3-C-(3,5-Di-O-benzoyl-1,2-O-isopropylidene-
h- -xylofuranos-3-yl)-5-methyl-1,2,4-oxadia-
D
zole (5).—A solution of 4 (1.24 g, 2.7 mmol) in
Ac2O (10 mL) was heated at 80 °C under
nitrogen for 20 h. The solvent was distilled off
and the resultant brown syrup was purified on
a column of silica gel chromatography using
petroleum–EtOAc as eluent to give white crys-
H, H-5a%), 4.58 (dd, 1 H, H-4%), 4.67 (d, J2%,1%
=
3.5 Hz, 1 H, H-2%), 4.88 (t, 1 H, exchangeable,
OH-3%), 6.00 (d, J1%,2%=3.5 Hz, 1 H, H-1%), 6.43
(s, 1 H, exchangeable, OH-5%), 7.63 (q, 2 H,
Bz–H-m), 7.72 (t, 1 H, Bz–H-p), 8.12 (q, 2 H,
Bz–H-o). 13C NMR (Me2SO-d6): 26.5 (–CH3),
26.6 (–CH3), 60.0 (C-5%), 78.0 (C-4%), 81.8
(C-2%), 86.0 (C-3%), 104.3 (–C[CH3]2), 111.6
(1%-C), 123.2 (Ph), 127.8 (Ph-m), 129.7 (Ph-o),
133.4 (Ph-p), 169.4 (C-3) 174.8 (C-5); FABMS:
m/z 335 [M+1]+. The crystal system is
orthorhombic, space group P22121, crystal
data: formula (C16H18O6N2)2, unit-cell vol-
ume V=3356.7(3) [3]. The details of unit-
cell parameters are: a=6.732(2), b=15.729
tals (1.06 g, 81%), mp 114–116 °C, [h]D18
+
1
72.95° (c 1.5, EtOAc); H NMR (Me2SO-d6):
1.29 (s, 3 H, –CH3), 1.41 (s, 3 H, –CH3), 2.14
(s, 3 H, –CH3), 4.45 (m, 1 H, H-5%b), 4.76 (dd,
1 H, H-4%), 5.10 (m, 1 H, H-5%a), 5.12 (d,
J2%,1%=3.5 Hz, 1 H, H-2%), 6.20 (d, J1%,2%=3.5
Hz, 1 H, H-1%), 8.11–7.50 (m, 10 H, Bz–H);
FABMS: m/z 481 [M+1]+. Anal. Calcd for
C25H24N2O8: C, 62.50; H, 5.03; N, 5.83.
Found: C, 62.68; H, 5.07; N, 5.69.
3-C-(3,5-Di-O-benzoyl-1,2-O-isopropylidene-
h- -xylofuranos-3-yl)-5-ethyl-1,2,4-oxadiaz-
D
ole (6).—Compound 4 (740 mg, 1.6 mmol)
was treated with propanoic anhydride (5 mL),
as in the procedure just described for the
preparation of 5, to give 6 (720 mg, 90%), mp
,
(1), c=31.701(1) A. Four molecules are con-
tained in one unit cell Z=4.
3-C-(Methyl h- -xylofuranosid-3-yl)-5-phe-
D
1
109–110, [h]1D8 +61.25° (c 0.8, EtOAc); H
nyl-1,2,4-oxadiazole (9) and 3-C-(methyl i- -
D
NMR (Me2SO-d6): 0.97 (t, 3 H, J=7.5 Hz,
–CH3), 1.28 (s, 3 H, –CH3), 1.42 (s, 3 H,
–CH3), 2.45 (q, 2 H, J=7.5 Hz, –CH2), 4.44
(m, 1 H, H-5%), 4.74 (dd, 1 H, H-4%), 5.09 (m,
1 H, H-5%%), 5.12 (d, J2%,1%=3.5 Hz, 1 H, H-2%),
6.18 (d, J1%,2=3.5 Hz, 1 H, H-1%), 8.10–7.47
(m, 10 H, Bz–H); FABMS: m/z 495 [M+1]+.
Anal. Calcd for C26H26N2O8: C, 63.15; H,5.30;
N, 5.66. Found: C, 63.25; H, 5.29; N, 5.61.
3-C-(3,5-Di-O-benzoyl-1,2-O-isopropylidene-
xylofuranosid-3-yl)-5-phenyl-1,2,4-oxadiazole
(10).—Compound 8 (470 mg, 1.4 mmol) was
treated with 1% anhydrous HCl–MeOH at rt
to give 9 (33 mg, 7.6%) and 10 (335 mg, 77%),
isolated by column chromatography using
petroleum–EtOAc as eluent. Compound 9 was
colorless crystals: mp 146–147 °C, [h]D18
+
1
25.7° (c 0.93, EtOAc); H NMR (Me2SO-d6):
3.42 (s, 3 H, OCH3-1%), 3.86 (dd, 1 H, H-4%),
3.96 (m, 2 H, H-5), 4.03 (d, 1 H, H-2%), 4.70 (d,
J1%,2%=0.0 Hz, 1 H, H-1%), 5.08 (1 H, OH-5%,
exchangeable), 5.09 (1 H, OH-2%, exchange-
able), 6.38 (1 H, OH-3%, exchangeable), 7.64
(m, 2 H, Ph–H), 7.70 (m, 1 H, Ph–H), 8.11 (d,
2 H, Ph–H); 13C NMR (Me2SO-d6): 56.0
(OCH3), 66.3 (C-4%), 69.0 (C-5%), 70.7 (C-2%),
99.7 (1%-C), 123.5 (Ph), 127.7 (Ph-m), 129.6
(Ph-o), 133.1 (Ph-p), 171.6 (C-3), 174.2 (C-5);
FABMS: m/z 309 [M+1]+. Anal. Calcd for
C14H16N2O6: C, 54.54; H, 5.23; N, 9.08.
Found: C, 54.59; H, 5.26; N, 9.10. Com-
pound 10 was colorless crystals: mp 181–
h - - xylofuranos-3-yl)-5-phenyl-1,2,4-oxadia-
D
zole (7).—Compound 4 (640 mg, 1.4 mmol)
was treated with BzCl (480 mg), as described
for the preparation of 5, to give 7 (660 mg,
85%), mp 154–155 °C, [h]1D8 +95.22° (c 0.77,
1
EtOAc); H NMR (Me2SO-d6): 1.33 (s, 3 H,
–CH3), 1.47 (s, 3 H, –CH3), 4.55 (m, 1 H,
H-5b%), 4.91 (dd, 1 H, H-4%), 5.22 (m, 1 H,
H-5a%), 5.38 (d, 1 H, J2,1=3.6 Hz, H-2%), 6.32
(d, J1,2 =3.6 Hz, 1 H, H-1%) 8.08–7.30 (m, 15
H, Bz–H, Ph–H); FABMS: m/z 557 [M+
1]+. Anal. Calcd for C31H28N2O8: C, 66.90; H,
5.07; N, 5.03. Found: C, 66.97; H, 5.32; N,
4.96.
1
82 °C, [h]1D8 −46.9° (c 1.6, EtOAc); H NMR
(Me2SO-d6): 3.40 (1 H, H-2%), 3.41 (s, 3 H,